Safety aspects of gene therapy

Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors.

Gene therapy·2016

A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay.

Gene therapy·2012

Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.

Bone marrow transplantation·2010

Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.

Gene therapy·2009

Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource.

Gene therapy·2008

A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.

Cancer gene therapy·2006

Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.

British journal of haematology·2026

Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.

British journal of haematology·2026

CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.

British journal of haematology·2026

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

British journal of haematology·2026

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

British journal of haematology·2026

Multiparameter flow cytometry versus droplet digital polymerase chain reaction for monitoring measurable residual disease in paediatric fusion gene-positive acute myeloid leukaemia.

British journal of haematology·2026

Pre-operative injectable testosterone therapy is associated with increased five-year revision risk after total shoulder arthroplasty: a TriNetX database analysis.

Journal of shoulder and elbow arthroplasty·2026

Methadone administration and QT interval prolongation: protocol for a systematic review and meta-analysis.

BMJ open·2026

ASSESSMENT OF MELATONIN USE PATTERNS, SAFETY, AND ATTITUDES TOWARD ITS USE IN ADULT POPULATION.

Georgian medical news·2026

Phage display-derived single-chain variable fragment antibody for highly sensitive and specific detection of thiamethoxam residues in food matrices.

Talanta·2026

EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Breast cancer after polyacrylamide hydrogel augmentation: A clinicopathological analysis of 5 cases and literature review.

Radiology case reports·2026

Related Experiment Videos

Safety aspects of gene therapy

Related Concept Videos

Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors.

A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay.

Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.

Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.

Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource.

A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.

Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.

Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.

CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

Multiparameter flow cytometry versus droplet digital polymerase chain reaction for monitoring measurable residual disease in paediatric fusion gene-positive acute myeloid leukaemia.

Pre-operative injectable testosterone therapy is associated with increased five-year revision risk after total shoulder arthroplasty: a TriNetX database analysis.

Methadone administration and QT interval prolongation: protocol for a systematic review and meta-analysis.

ASSESSMENT OF MELATONIN USE PATTERNS, SAFETY, AND ATTITUDES TOWARD ITS USE IN ADULT POPULATION.

Phage display-derived single-chain variable fragment antibody for highly sensitive and specific detection of thiamethoxam residues in food matrices.

EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.

Breast cancer after polyacrylamide hydrogel augmentation: A clinicopathological analysis of 5 cases and literature review.

Related Experiment Videos

Safety aspects of gene therapy

Related Concept Videos

Related Articles